Panasonic Develops Automated iPS Cell Production System — Toward a 50× Cost Reduction

Source:Yomiuri Shimbun (Yomiuri Online)“iPS細胞を患者の血液から自動で作製できる装置を開発”Published April 20, 2026https://www.yomiuri.co.jp/science/20260420-GYT1T00298 ⚙️ From Handmade Cells to “Push-Button Biology” Creating iPS cells today is a bit like crafting a luxury watch:highly precise, extremely delicate — and very expensive. Now, Panasonic Holdings wants to turn that process into something closer to pressing a button. On April 20, 2026, the company announced … Read more

A “Bio-Artificial Liver” from iPS Cells — Japan Develops External Device That Could Replace Transplants

Source:Yomiuri Shimbun (Yomiuri Online)“iPS細胞で『バイオ人工肝臓』、体外装置で移植せず治療可能に…3年以内に小児患者で臨床研究”Published May 1, 2026https://www.yomiuri.co.jp/medical/20260501-GYT1T00116/ 🫀 What If You Didn’t Need a Liver Transplant? For decades, severe liver failure has had one ultimate solution:transplantation. But what if you didn’t need a new liver at all?What if you could simply… borrow one for a few hours? A research team from Osaka University and Tokyo … Read more

Japan Approves World’s First iPS Cell-Based Therapy — A Historic Step from Lab to Life

Source:Ministry of Education, Culture, Sports, Science and Technology (MEXT)Minister’s Statement: “Approval of the World’s First Regenerative Medicine Product Using iPS Cells”March 6, 2026https://www.mext.go.jp/b_menu/daijin/detail/mext_00672.html 🌍 A Scientific Dream Becomes RealityOn March 6, 2026, Japan reached a milestone that scientists have been chasing for nearly two decades:a regenerative medicine product derived from iPS cells was officially approved … Read more

Teijin and Australia’s Cell Therapies Form Strategic Partnership for Cell & Gene Therapy CDMO Business Across Asia-Pacific

Source:Teijin Limited & Cell Therapies Pty Ltd.“Strategic Business Alliance on Cell and Gene Therapy CDMO in the Asia-Pacific Region” (October 1, 2025)Official Press Release PDF (Japanese) 🌏 Overview 🧬 Background: Rising Demand for Cell & Gene Therapy CDMO The demand for CDMO services in regenerative medicine has been surging, driven by the increasing complexity of … Read more

Japan’s Ministry of Health Issues New Safety Guideline for Regenerative Medicine — “Microbiological Safety of Specified Cell-Processed Products”

Source: Ministry of Health, Labour and Welfare (MHLW), Japan“Guideline on the Microbiological Safety of Specified Cell-Processed Products” (Issued October 6, 2025)(Official PDF, Japanese)MHLW Regenerative Medicine Information Portal 🩺 OverviewOn October 6, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) released a new national guideline titled“Guideline on the Microbiological Safety of Specified Cell-Processed Products.” This … Read more

Kyoto University Keeps Winning Nobel Prizes — Japan’s “Free Spirits” of Science

「ノーベル賞、科学系は京大卒が10人となり最多 『まだ底力ある』」「京都大学、やっぱり我々はまだきちんと底力を持っているんだなと、自分で言うのも変ですけれど、心から誇り高い気持ちでいっぱい」— Asahi Shimbun via Yahoo! News Japan, news.yahoo.co.jp/articles/1ea6eebf935d4b11f4005bc819f1334265052448 Japan’s Academic Powerhouse Does It AgainKyoto University, Japan’s famously independent-minded institution, has done it again — producing not one but two Nobel Prize laureates in 2025:Shimon Sakaguchi (Physiology or Medicine) and Susumu Kitagawa (Chemistry). With their wins, Kyoto University now boasts 10 Nobel laureates in the sciences … Read more

Final English Article (with Japanese Source Citation Up Front)

「ノーベル生理学・医学賞、坂口志文氏ら3人 『制御性T細胞』特定」授賞理由は「末梢免疫寛容に関する発見」で、自己免疫疾患やがん治療に新たな可能性を開いた。 — Reuters Japan, jp.reuters.com Japan’s “Immune Peacekeeper” Wins the 2025 Nobel Prize in Medicine When your immune system gets confused, it can wage war — not on viruses, but on you.Luckily, a calm and persistent Japanese scientist has spent decades figuring out how to stop that friendly fire. On October 6 2025, the … Read more